VAERS Explorer
Back to explore

Report #2842186

Received May 22, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Female
Age
Age unknown
State
FL
Recovered
Recovered
Vaccinated
—
Onset
—
Days to onset
—
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
VARZOSZOSTER (SHINGRIX)GLAXOSMITHKLINE BIOLOGICALS1——

Symptoms (2)

Herpes zosterRash

Symptom narrative

Shingles; This non-serious case was reported by a consumer via call center representative and described the occurrence of shingles in a elderly female patient who received Herpes zoster (Shingrix) for prophylaxis. Concurrent medical conditions included blood pressure high and blood cholesterol increased. Concomitant products included atenolol, losartan, simvastatin and acetylsalicylic acid (Aspirin). On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, 2 days after receiving Shingrix, the patient experienced shingles (Verbatim: Shingles). The patient was treated with aciclovir sodium (Acyclovir) and bentonite, calamine, phenol, zinc oxide (Calamine). The outcome of the shingles was resolved. It was unknown if the reporter considered the shingles to be related to Shingrix. It was unknown if the company considered the shingles to be related to Shingrix. Additional Information: GSK Receipt Date: 15-MAY-2025 The reporter was the patient who received 2 doses of Shingrix last year. 2 days after each dose, she experienced a rash on her right buttock that was diagnosed as shingles. It was the size of a silver dollar and in both instances, the rash was in the same spot. It did not get bigger or spread. Her doctor prescribed acyclovir 400 mg and the rash went away after 1 or 2 weeks. She also applied calamine lotion to the rash in addition to taking acyclovir. For tolerance of 2nd dose of Shingrix, refer case US2025AMR060778.; Sender's Comments: US-GSK-US2025AMR060778:same patient/Dose 2

Current illness

Blood cholesterol increased; Blood pressure high

Other medications

ATENOLOL; LOSARTAN; SIMVASTATIN; ASPIRIN